Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Premedication in Geriatric ESRD Patients for Hip Fracture Surgery
NCT01837290Phase 3Completed
- Sponsor
- Baskent University
- Start
- Dec 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in hip fracture, sponsored by Baskent University. Started Dec 2012; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT01837290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837290.